The Long Read: CEOs Unplug At AAM Conference
Four US Leaders Dive Deep On PBMs, Pricing, Biosimilars And Shortages
The AAM’s annual Access! 2024 conference brought its much-enjoyed CEOs Unplugged panel to Tampa again for another engaging discussion on critical issues, challenges and opportunities for generics and biosimilars in the US.
